{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:16Z","timestamp":1740144196799,"version":"3.37.3"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["the Natural Science Foundation of China (No. Grant number: 81373381)"],"award-info":[{"award-number":["the Natural Science Foundation of China (No. Grant number: 81373381)"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"crossref","award":["2017ZX09304029"],"award-info":[{"award-number":["2017ZX09304029"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Provincial Health Committee key project: Evidence-based research on monitoring methods and evaluation tools for rational use of antibacterials in children","award":["No. 18ZD042"],"award-info":[{"award-number":["No. 18ZD042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>In the study's early stage, the research group had established an evaluation index system for the rational drug use of primary nephrotic syndrome in children. To assess the feasibility of the established index system, we conducted this empirical study.<\/jats:p>\n            <jats:p>The cross-sectional study was conducted by using the Hospital Information System to extract some general clinical data of hospitalized children with primary nephrotic syndrome, which included registration number, age, sex, diagnosis and medication, etc. Utilize the SPSS23.0 software and Excel 2016 to descriptively analyze information.<\/jats:p>\n            <jats:p>224 hospitalized children with primary nephrotic syndrome who met the inclusion criteria were included, ranging from 18 years old and 10 months to 11 months and 23 days, with an average age of 8.40, plus or minus 4.30 years. 148 males (66.07%) and 76 females (33.93%). The duration of hospitalization was 1\u201357 days, with an average hospitalization time of 10.59 days. The most common is respiratory infections, such as the bronchopneumonia, the mycoplasma pneumonia, etc. This study had successfully completed the measurement of the evaluation index system for the rational drug use of primary nephrotic syndrome in children.<\/jats:p>\n            <jats:p>All indicators are feasible, but the operability and applicability need further research and improvement.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021564","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T20:01:12Z","timestamp":1596571272000},"page":"e21564","source":"Crossref","is-referenced-by-count":0,"title":["An empirical study on the index system of rational drug use in children with primary nephrotic syndrome"],"prefix":"10.1097","volume":"99","author":[{"given":"Mao","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"},{"name":"West China School of Pharmacy, Sichuan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"},{"name":"Cochrane China Center, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"},{"name":"Cochrane China Center, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"},{"name":"Cochrane China Center, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"R1-20230915","first-page":"183","article-title":"Promoting rational use of medicines: core components","year":"2002","journal-title":"WHA"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jebm.12244","article-title":"Indicators for assessing quality of drug use: a systematic literature review","volume":"10","author":"Song","year":"2017","journal-title":"J Evid Based Med"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00467-002-1056-2","article-title":"Nephmtic syndrome associated with human parvovirus B19 infection","volume":"18","author":"Ohtomo","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00467-008-1062-0","article-title":"Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome","volume":"24","author":"Dharmaraj","year":"2009","journal-title":"Pediatr Nephol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/nep.12638","article-title":"Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome","volume":"21","author":"Aggarwal","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00198-011-1836-2","article-title":"Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis","volume":"23","author":"Yimaz","year":"2012","journal-title":"Osteoporos Int"},{"key":"R8-20230915","first-page":"759","article-title":"The manifestations of bone metabolism related indicators in children with primary nephrotic syndrome","volume":"35","author":"Zhang","year":"2017","journal-title":"Journal of Clinical Pediatrics"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11255-012-0264-3","article-title":"Effects of cyclosporine on bone mineral density in patients with glucocorticoid dependent nephrotic syndrome in remission","volume":"45","author":"Shimizu","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10157-014-1031-9","article-title":"Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy","volume":"19","author":"Kaku","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02761198","article-title":"High dose methylprednisolone therapy in nephrotic syndrome","volume":"66","author":"Mocan","year":"1999","journal-title":"Indian J Pediatr"},{"key":"R13-20230915","first-page":"705","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"66","author":"Investigators","year":"2008","journal-title":"Kardiologia Polska"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:43:10Z","timestamp":1694824990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021564"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":11,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021564","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}